The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Over the last decade, the introduction of microarray technology has had a profound impact on gene expression research. The publication of studies with dissimilar or altogether contradictory results, obtained using different microarray platforms to analyze identical RNA samples, has raised concerns about the reliability of this technology. The MicroArray Quality Control (MAQC) project was initiated to address these concerns, as well as other performance and data analysis issues. Expression data on four titration pools from two distinct reference RNA samples were generated at multiple test sites using a variety of microarray-based and alternative technology platforms. Here we describe the experimental design and probe mapping efforts behind the MAQC project. We show intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed. This study provides a resource that represents an important first step toward establishing a framework for the use of microarrays in clinical and regulatory settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Next, we applied the |log 2 fold-change|>1 filter advocated in the MAQC study on microarrays, 10 and for microarrays observed a reduction in the eFDR to below 1.5%, save for one outlier site (Figs 3c,d).”
From A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium (2014) · cites this paper as [10]
In the citing paper
“Studies on microarrays have shown that results of typical statistical differential expression tests thresholded by p -value need to be filtered and sorted by effect strength (fold-change) in order to attain robust comparisons across platforms and sites. 10”
From A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium (2014) · cites this paper as [10]
In the citing paper
“The Microarray Quality Control (MAQC) Consortium landmark study10 examined the degree of variance within and across many different microarray platforms and found similar coefficients of variation between platforms.”
From Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study (2014) · cites this paper as [10]
In the citing paper
“prior work comparing microarray platforms and methods showed high levels of inter-platform concordance for the ability to detect differentially expressed genes.”
From Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study (2014) · cites this paper as [10]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,481 · cited 1×
“We mapped the probes (see Supplementary Methods online and Supplementary Notes online) to the RefSeq human mRNA databas”
Method"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,709
Pruitt, K. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki025 · Cited by 1,660 · cited 1×
“We mapped the probes (see Supplementary Methods online and Supplementary Notes online) to the RefSeq human mRNA database 31 (http://www.ncbi.nlm.nih.gov/RefSeq) and to the AceView database 32 (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly), a less curated but more comprehensive database, which…”
MethodA Stem Cell Molecular Signature
Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A., & Lemischka, I. R. (2002) · Science · doi:10.1126/science.1073823 · Cited by 1,542
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025 · cited 1×
“, raising doubts about the repeatability, reproducibility and comparability of microarray technolog”
BackgroundMultiple-laboratory comparison of microarray platforms
Irizarry, R. A., Warren, D., Spencer, F., Kim, I. F., Biswal, S., Frank, B. C., Gabrielson, E., Garcia, J. G. N., Geoghegan, J., Germino, G., et al. (2005) · Nature Methods · doi:10.1038/nmeth756 · Cited by 862
Self-citationEvaluation of gene expression measurements from commercial microarray platforms
Tan, P. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg763 · Cited by 706
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
Ein-Dor, L., Zuk, O., & Domany, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601231103 · Cited by 689 · cited 1×
“…to appear in peer-reviewed journals 9,10 , raising doubts about the repeatability, reproducibility and comparability of microarray technology 11–13 , several studies have also been recently published showing increased reproducibility of microarray data generated at different test sites and/or…”
Background
Research works printed but not linked: 1
- Reid, L.H. The value of a proficiency testing program to monitor performance in microarray laboratories. Pharm. Discov. 5, 20–25 (2005).
Cited by
Items 101–200 of 1,004
Kohlmann, A., Kipps, T. J., Rassenti, L. Z., Downing, J. R., Shurtleff, S. A., Mills, K. I., Gilkes, A. F., Hofmann, W., Basso, G., Dell’Orto, M. C., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07261.x · Cited by 219
A comprehensive functional analysis of tissue specificity of human gene expression
Dezső, Z., Nikolsky, Y., Sviridov, E., Shi, W., Serebriyskaya, T., Dosymbekov, D., Bugrim, A., Rakhmatulin, E., Brennan, R. J., Guryanov, A., et al. (2008) · BMC Biology · doi:10.1186/1741-7007-6-49 · Cited by 218
Self-citationWeaver, S., Dube, S., Mir, A., Qin, J., Sun, G., Ramakrishnan, R., Jones, R. C., & Livak, K. J. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.003 · Cited by 220
Standardization and quality management in next-generation sequencing
Endrullat, C., Glökler, J., Franke, P., & Frohme, M. (2016) · Applied & Translational Genomics · doi:10.1016/j.atg.2016.06.001 · Cited by 212
VOLCANO PLOTS IN ANALYZING DIFFERENTIAL EXPRESSIONS WITH mRNA MICROARRAYS
LI, W. (2012) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720012310038 · Cited by 204
Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology
Sato, F., Tsuchiya, S., Terasawa, K., & Tsujimoto, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005540 · Cited by 216
“In the MAQC project, seven different platforms (Applied Biosystems, Affymetrix, Agilent, Eppendolf, GE Healthcare, Illumina, and NCI array) were compared [6].”
MethodUse cases, best practice and reporting standards for metabolomics in regulatory toxicology
Viant, M. R., Ebbels, T. M. D., Beger, R. D., Ekman, D. R., Epps, D. J. T., Kamp, H., Leonards, P. E. G., Loizou, G. D., MacRae, J. I., van Ravenzwaay, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10900-y · Cited by 204
Predictive and prognostic molecular markers for cancer medicine
Mehta, S., Shelling, A., Muthukaruppan, A., Lasham, A., Blenkiron, C., Laking, G., & Print, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834009360519 · Cited by 210
“data quality [Shi et al. 2006], although they are likely to be replaced in the next 10 years by the emerging technologies described below.”
BackgroundMining gene expression profiles: expression signatures as cancer phenotypes
Nevins, J. R., & Potti, A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2137 · Cited by 211
Tsai, M.-S., Hwang, S.-M., Chen, K.-D., Lee, Y.-S., Hsu, L.-W., Chang, Y.-J., Wang, C.-N., Peng, H.-H., Chang, Y.-L., Chao, A.-S., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0023 · Cited by 209
“As long as the manufacturer’s protocols are strictly followed, Affymetrix chips have been shown to have good interlaboratory reproducibility [ 33 ].”
BackgroundResultInfluentialSelf-citationThomas, R. S., Allen, B. C., Nong, A., Yang, L., Bermudez, E., Clewell, H. J., & Andersen, M. E. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm092 · Cited by 207
“Microarray technology has been broadly accepted as an efficient and reproducible way to simultaneously measure the expression of thousands of genes (Shi et al., 2006).”
BackgroundFielden, M. R., Brennan, R., & Gollub, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm156 · Cited by 205
“The repression of Tsc-22 mRNA was also tested as a biomarker, since it has been shown to be repressed by a variety of nongenotoxic hepatocarcinogens in both mouse and rat (Kramer et al., 2004; Iida et al., 2005; Michel et al., 2005) and has been observed to be repressed in some human tumor samples ( Rentsch et al., 20…”
BackgroundLuo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr299 · Cited by 206
“Though high throughput technology such as microarray has the potential to generate large quantities of data for analyzing drug–drug associations, this methodology, although robust, can also be costly (25,26) while reliability and quality measures still need to be improved (27,28).”
BackgroundSelf-citationGlycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin Microarray
Tateno, H., Toyota, M., Saito, S., Onuma, Y., Ito, Y., Hiemori, K., Fukumura, M., Matsushima, A., Nakanishi, M., Ohnuma, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231274 · Cited by 201
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
Noble, C. L., Abbas, A. R., Cornelius, J., Lees, C. W., Ho, G.-T., Toy, K., Modrusan, Z., Pal, N., Zhong, F., Chalasani, S., et al. (2008) · Gut · doi:10.1136/gut.2008.148395 · Cited by 205
Identifying differentially expressed transcripts from RNA-seq data with biological variation
Glaus, P., Honkela, A., & Rattray, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts260 · Cited by 198
“published by Shi et al. (2006). aWe were not able to use the default bias correction provided by MMSEQ (Turro et al.”
MethodCohen, L., Cole, S. W., Sood, A. K., Prinsloo, S., Kirschbaum, C., Arevalo, J. M. G., Jennings, N. B., Scott, S., Vence, L., Wei, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042324 · Cited by 197
“thresholds yield more replicable results than do p-value-based thresholds [35,36,37,38,39,40].”
BackgroundChemoprevention of liver cancer by plant polyphenols
Stagos, D., Amoutzias, G. D., Matakos, A., Spyrou, A., Tsatsakis, A. M., & Kouretas, D. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.04.002 · Cited by 197
Large Scale Comparison of Gene Expression Levels by Microarrays and RNAseq Using TCGA Data
Guo, Y., Sheng, Q., Li, J., Ye, F., Samuels, D. C., & Shyr, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071462 · Cited by 191
“The Microarray Quality Control (MAQC) project has shown that there is a high level of intra-platform consistency across test sites and inter-platform concordance in terms of genes identified as differentially expressed by microarray methods [4].”
BackgroundAn overview of heat stress in tomato (Solanum lycopersicum L.)
Alsamir, M., Mahmood, T., Trethowan, R., & Ahmad, N. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.11.088 · Cited by 165
Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury
Lei, P., Li, Y., Chen, X., Yang, S., & Zhang, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.074 · Cited by 193
“These results suggest that the quality of the chips we used in this study meet the requirements for microRNA study (Arikawa et al., 2008; Eisenstein, 2006; Shi et al., 2006; Shi et al., 2008).”
MethodDifferential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
Hu, Y., Li, P., Hao, S., Liu, L., Zhao, J., & Hou, Y. (2009) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2009.228 · Cited by 193
“Several previous in depth comparative studies between microarray platforms and analysis procedures have indicated the very high reproducibility, sensitivity, and specificity of similar expression microarrays when using the recommended procedures (12, 13).”
MethodAnalysis of omics data with genome-scale models of metabolism
Hyduke, D. R., Lewis, N. E., & Palsson, B. Ø. (2012) · Molecular BioSystems · doi:10.1039/c2mb25453k · Cited by 179
Gong, Y., Yan, K., Lin, F., Anderson, K., Sotiriou, C., Andre, F., Holmes, F. A., Valero, V., Booser, D., Pippen, J. E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70042-6 · Cited by 195
Self-citationNext-generation sequencing and its applications in molecular diagnostics
Su, Z., Ning, B., Fang, H., Hong, H., Perkins, R., Tong, W., & Shi, L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.3 · Cited by 179
Self-citationBlood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage
Chen, Y., Zheng, Y., Yu, Y., Wang, Y., Huang, Q., Qian, F., Sun, L., Song, Z., Chen, Z., Feng, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105896 · Cited by 187
“This straightforward approach of combining a fold change cutoff with a non-stringent P -value threshold has been demonstrated to yield reproducible and robust lists of DEGs for both microarray and RNA-seq-based gene expression analyses (Shi et al , 2006; Su et al , 2014b).”
Self-citationInhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
Zhou, L., Nguyen, A. N., Sohal, D., Ying Ma, J., Pahanish, P., Gundabolu, K., Hayman, J., Chubak, A., Mo, Y., Bhagat, T. D., et al. (2008) · Blood · doi:10.1182/blood-2008-02-139824 · Cited by 184
Bronevetsky, Y., Villarino, A. V., Eisley, C. J., Barbeau, R., Barczak, A. J., Heinz, G. A., Kremmer, E., Heissmeyer, V., McManus, M. T., Erle, D. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20111717 · Cited by 189
“Because qRTPCR does not suffer from the data compression inherent in hybridization-based array analyses, it provides a more accurate measure of the magnitude of miRNA down-regulation (Shi et al., 2006).”
BackgroundQuantifying Killing of Orangutans and Human-Orangutan Conflict in Kalimantan, Indonesia
Meijaard, E., Buchori, D., Hadiprakarsa, Y., Utami-Atmoko, S. S., Nurcahyo, A., Tjiu, A., Prasetyo, D., Nardiyono, Christie, L., Ancrenaz, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027491 · Cited by 177
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
Petri, M., Singh, S., Tesfasyone, H., Dedrick, R., Fry, K., Lal, P., Williams, G., Bauer, J., Gregersen, P., Behrens, T., et al. (2009) · Lupus · doi:10.1177/0961203309105529 · Cited by 182
On the stability of feature selection algorithms
NogueiraSarah, SechidisKonstantinos, & BrownGavin (2017) · Journal of Machine Learning Research · doi:10.5555/3122009.3242031 · Cited by 138
Becker, A. M., Dao, K. H., Han, B. K., Kornu, R., Lakhanpal, S., Mobley, A. B., Li, Q.-Z., Lian, Y., Wu, T., Reimold, A. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067003 · Cited by 186
“The precision of our microarrays have been demonstrated previously [18].”
MethodSelf-citationSu, Z., Fang, H., Hong, H., Shi, L., Zhang, W., Zhang, W., Zhang, Y., Dong, Z., Lancashire, L. J., Bessarabova, M., et al. (2014) · Genome Biology · doi:10.1186/s13059-014-0523-y · Cited by 179
“The two rat data sets were from the NCTR rat toxicogenomics study [20,21] and the FDA SEquencing Quality Control (SEQC) rat toxicogenomics study [22]; and the three human data sets were from the FDA SEQC main study [16], MicroArray Quality Control (MAQC) phase I main study [23], the SEQC neuroblastoma (NB) study, and…”
BackgroundMethodSelf-citationThe Future of Fisheries Science in North America
(2009) · Springer eBooks · doi:10.1007/978-1-4020-9210-7 · Cited by 181
Toward a Predictive Understanding of Earth’s Microbiomes to Address 21st Century Challenges
Blaser, M. J., Cardon, Z. G., Cho, M. K., Dangl, J. L., Donohue, T. J., Green, J. L., Knight, R., Maxon, M. E., Northen, T. R., Pollard, K. S., et al. (2016) · mBio · doi:10.1128/mbio.00714-16 · Cited by 172
Digital transcriptome profiling using selective hexamer priming for cDNA synthesis
Armour, C. D., Castle, J. C., Chen, R., Babak, T., Loerch, P., Jackson, S., Shah, J. K., Dey, J., Rohl, C. A., Johnson, J. M., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1360 · Cited by 176
Self-citationLin, Y., Golovnina, K., Chen, Z.-X., Lee, H. N., Negron, Y. L. S., Sultana, H., Oliver, B., & Harbison, S. T. (2016) · BMC Genomics · doi:10.1186/s12864-015-2353-z · Cited by 171
“The MAQC Consortium identified and quantified the degree of variability and reproducibility both within and across different microarray platforms [15].”
Van Aggelen, G., Ankley, G. T., Baldwin, W. S., Bearden, D. W., Benson, W. H., Chipman, J. K., Collette, T. W., Craft, J. A., Denslow, N. D., Embry, M. R., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0900985 · Cited by 170
“For transcriptomics in fish, diversity of micro array platforms has precluded inter laboratory com parisons, but interlaboratory micro array com parison has been successful for mammalian species (e.g., Mattes 2008; Shi et al. 2006).”
MethodDetecting and correcting systematic variation in large-scale RNA sequencing data
Li, S., Łabaj, P. P., Zumbo, P., Sykacek, P., Shi, W., Shi, L., Phan, J., Wu, P.-Y., Wang, M., Wang, C., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3000 · Cited by 175
Self-citationAssessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
“In part, they might be due to a lack of standardization; although, standards such as MIAME [107] are continuously improving the reproducibility and transferability of results, and studies such as MACQC [108] have shown good reproducibility between different array technologies.”
BackgroundUsing RNA sample titrations to assess microarray platform performance and normalization techniques
Shippy, R., Fulmer-Smentek, S., Jensen, R. V., Jones, W. D., Wolber, P. K., Johnson, C. D., Pine, P. S., Boysen, C., Guo, X., Chudin, E., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1241 · Cited by 173
Self-citationCytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
Kunz, M., & Ibrahim, S. M. (2009) · Mediators of Inflammation · doi:10.1155/2009/979258 · Cited by 170
“Interestingly, S100A8, S100A12, IL1B, and IL1R2 were highly expressed in PBMC of a rat and murine model of CIA and were suggested as markers for disease activity [121].”
BackgroundResultInfluentialImpact of normalization on miRNA microarray expression profiling
Pradervand, S., Weber, J., Thomas, J., Bueno, M., Wirapati, P., Lefort, K., Dotto, G. P., & Harshman, K. (2009) · RNA · doi:10.1261/rna.1295509 · Cited by 173
Mills, K. I., Kohlmann, A., Williams, P. M., Wieczorek, L., Liu, W.-M., Li, R., Wei, W., Bowen, D. T., Loeffler, H., Hernandez, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-10-187203 · Cited by 167
“Intermediate (any abnormalities) 19 (12) 14 (10) 12 (11)”
Arikawa, E., Sun, Y., Wang, J., Zhou, Q., Ning, B., Dial, S. L., Guo, L., & Yang, J. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-328 · Cited by 167
Self-citationGullapalli, R. R., Desai, K. V., Santana-Santos, L., Kant, J. A., & Becich, M. J. (2012) · Journal of Pathology Informatics · doi:10.4103/2153-3539.103013 · Cited by 157
“Guidelines for standardization of NGS protocols, along the lines of-efforts initiated by the FDA: the microarray quality control (MAQC) project [73] and the sequencing quality control (SEQC) project (http:// www.fda.gov/MicroArrayQC/), will be particularly important for NGS going forward.”
BackgroundCancer gene expression signatures – The rise and fall?
Chibon, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.021 · Cited by 164
Asmann, Y. W., Klee, E. W., Thompson, E. A., Perez, E. A., Middha, S., Oberg, A. L., Therneau, T. M., Smith, D. I., Poland, G. A., Wieben, E. D., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-531 · Cited by 161
Self-citationNacu, S., Yuan, W., Kan, Z., Bhatt, D., Rivers, C. S., Stinson, J., Peters, B. A., Modrusan, Z., Jung, K., Seshagiri, S., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-11 · Cited by 167
“We applied both methods to sets of single-end reads that we obtained by sequencing the transcriptomes of three primary human prostate adenocarcinomas (denoted by T1, T2, and T3) and their matched normal samples (N1, N2, and N3), as well as the human brain reference (HBR) and universal human reference (UHR) samples use…”
MethodFlygare, S., Simmon, K., Miller, C., Qiao, Y., Kennedy, B., Di Sera, T., Graf, E. H., Tardif, K. D., Kapusta, A., Rynearson, S., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0969-1 · Cited by 164
“In the first experiment, we employed qPCR results taken from the microarray quality control study (MAQC) [48]; specifically, human brain tissue samples (Additional file 1: Table S12).”
MethodMalkov, V. A., Serikawa, K. A., Balantac, N., Watters, J., Geiss, G., Mashadi-Hossein, A., & Fare, T. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-80 · Cited by 161
“This distinction is important because the MAQC study showed that UHR has 1.5-fold higher mRNA content than Brain (3% vs. 2%).”
MethodInfluentialA two-parameter generalized Poisson model to improve the analysis of RNA-seq data
Srivastava, S., & Chen, L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq670 · Cited by 152
“To validate our differentially expressed genes, we also utilized the quantitative real-time PCR (qRT-PCR) data for the MAQC-2 samples (12).”
MethodCamps, C., Saini, H. K., Mole, D. R., Choudhry, H., Reczko, M., Guerra-Assunção, J., Tian, Y.-M., Buffa, F. M., Harris, A. L., Hatzigeorgiou, A. G., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-28 · Cited by 157
“The Illumina platform was chosen as it performed well in large comparative studies [56].”
MethodMeta-analytic support vector machine for integrating multiple omics data
Kim, S., Jhong, J.-H., Lee, J., & Koo, J.-Y. (2017) · BioData Mining · doi:10.1186/s13040-017-0126-8 · Cited by 159
The genomics of the human endometrium
Ruíz-Alonso, M., Blesa, D., & Simón, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.004 · Cited by 162
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma
Satow, R., Shitashige, M., Kanai, Y., Takeshita, F., Ojima, H., Jigami, T., Honda, K., Kosuge, T., Ochiya, T., Hirohashi, S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2214 · Cited by 170
“To extract differentially expressed genes from the array data, a paired t test with no correction was done (19) with asymptotic distribution to determine the P value.”
MethodMav, D., Shah, R. R., Howard, B. E., Auerbach, S. S., Bushel, P. R., Collins, J. B., Gerhold, D. L., Judson, R. S., Karmaus, A. L., Maull, E. A., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191105 · Cited by 155
Two gene co-expression modules differentiate psychotics and controls
Chen, C., Cheng, L., Grennan, K., Pibiri, F., Zhang, C., Badner, J. A., Members of the Bipolar Disorder Genome Study (BiGS) Consortium, Gershon, E. S., & Liu, C. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.146 · Cited by 157
Self-citationA Decade of Toxicogenomic Research and Its Contribution to Toxicological Science
Chen, M., Zhang, M., Borlak, J., & Tong, W. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs223 · Cited by 152
Self-citationGene-expression-based prognostic assays for breast cancer
Kim, C., & Paik, S. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.61 · Cited by 161
“Microarray-based measurements of gene expression are surprisingly reproducible as demonstrated by the MicroArray Quality Control project, which sent the same starting materials to many different laboratories and tested the reproducibility of many array platforms with a coefficient of variation median of 10–20%”
MethodGetting Started in Gene Expression Microarray Analysis
Slonim, D. K., & Yanai, I. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000543 · Cited by 152
Foxl2functions in sex determination and histogenesis throughout mouse ovary development
García‐Ortíz, J. E., Pelosi, E., Omari, S., Nedorezov, T., Piao, Y., Karmazin, J., Uda, M., Cao, A., Cole, S. W., Forabosco, A., et al. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-36 · Cited by 164
A Genomic Approach to Human Autoimmune Diseases
Pascual, V., Chaussabel, D., & Banchereau, J. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101221 · Cited by 146
Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data
Chen, J. J., Hsueh, H.-M., Delongchamp, R. R., Lin, C.-J., & Tsai, C.-A. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-412 · Cited by 147
Self-citationKanitz, A., Gypas, F., Gruber, A. J., Gruber, A. R., Martin, G., & Zavolan, M. (2015) · Genome Biology · doi:10.1186/s13059-015-0702-5 · Cited by 140
“Independently and comprehensively evaluating the accuracy of such computational methods is difficult, because experimental validation strategies by, for example, quantitative PCR are typically restricted to just a limited number of isoforms (see, for example, [22]).”
Backgrounddtangle: accurate and robust cell type deconvolution
Hunt, G. J., Freytag, S., Bahlo, M., & Gagnon-Bartsch, J. A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty926 · Cited by 154
CcpA Regulates Central Metabolism and Virulence Gene Expression in Streptococcus mutans
Abranches, J., Nascimento, M. M., Zeng, L., Browngardt, C. M., Wen, Z. T., Rivera, M. F., & Burne, R. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01237-07 · Cited by 147
“The advantages of using a reference RNA in microarray studies are described elsewhere (30, 38 ).”
MethodThomas, R. S., Clewell, H. J., Allen, B. C., Wesselkamper, S. C., Wang, N. C. Y., Lambert, J. C., Hess-Wilson, J. K., Zhao, Q. J., & Andersen, M. E. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq355 · Cited by 142
“(Abdueva et al., 2007; Shi et al., 2006; Shippy et al., 2006), and extensive validation studies performed by the MicroArray Quality Control project demonstrated consistent results across multiple platforms and research sites (Shi et al., 2006).”
BackgroundZheng, Y., Liu, Y., Yang, J., Dong, L., Zhang, R., Tian, S., Yu, Y., Ren, L., Hou, W., Zhu, F., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01934-1 · Cited by 178
“Precision and recall are widely used QC metrics for qualitative genomic variant calling 58–60 , whereas correlation coefficients are widely used for quantitative omics profling 55,56,61–64 .”
BackgroundMethodInfluentialSelf-citationLiu, S., Lin, L., Jiang, P., Wang, D., & Xing, Y. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq817 · Cited by 146
“Does RNA-Seq also tend to have increased false positives for lowly expressed genes? To address these questions, we compared RNA-Seq and TaqMan qPCR data of two human reference RNA samples in the MAQC project (35).”
BackgroundMethodInfluentialFoley, J. W., Zhu, C., Jolivet, P., Zhu, S., Lu, P., Meaney, M. J., & West, R. B. (2019) · Genome Research · doi:10.1101/gr.234807.118 · Cited by 151
ΔFosB Induction in Orbitofrontal Cortex Mediates Tolerance to Cocaine-Induced Cognitive Dysfunction
Winstanley, C. A., LaPlant, Q., Theobald, D. E. H., Green, T. A., Bachtell, R. K., Perrotti, L. I., DiLeone, R. J., Russo, S. J., Garth, W. J., Self, D. W., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2566-07.2007 · Cited by 143
Durrenberger, P. F., Fernando, F. S., Kashefi, S. N., Bonnert, T. P., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P. J., Falkai, P., Grünblatt, E., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1293-0 · Cited by 139
Microarray experiments and factors which affect their reliability
Jaksik, R., Iwanaszko, M., Rzeszowska‐Wolny, J., & Kimmel, M. (2015) · Biology Direct · doi:10.1186/s13062-015-0077-2 · Cited by 170
“Despite successful studies of reproducibility [27] and specificity [97], microarrays have been often subject of criticism as a method which fails to identify relevant information that can be transferred directly into clinical applications [98].”
BackgroundSha, Y., Phan, J. H., & Wang, M. D. (2015) · 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7319872 · Cited by 126
“We use four-fold instead of the twofold advocated in the MAQC study [17] to improve stringency.”
MethodApplication of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity
Ellinger-Ziegelbauer, H. C., Aubrecht, J., Kleinjans, J. C. S., & Ahr, H.-J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.08.017 · Cited by 143
Wang, T., Johnson, T. S., Shao, W., Lu, Z., Helm, B. R., Zhang, J., & Huang, K. (2019) · Genome Biology · doi:10.1186/s13059-019-1764-6 · Cited by 140
Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study
Foox, J., Tighe, S. W., Nicolet, C. M., Zook, J. M., Byrska-Bishop, M., Clarke, W. E., Khayat, M. M., Mahmoud, M., Laaguiby, P. K., Herbert, Z. T., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01049-5 · Cited by 138
Self-citationChhangawala, S., Rudy, G., Mason, C. E., & Rosenfeld, J. (2015) · Genome biology · doi:10.1186/s13059-015-0697-y · Cited by 143
Yu, T., Wang, X.-Y., Gong, R.-G., Li, A., Yang, S., Cao, Y.-T., Wen, Y.-M., Wang, C.-M., & Yi, X.-Z. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-64 · Cited by 141
“Stem-loop qRT-PCR for miRNAs Our miRNA microarray detection platform was constructed by CapitalBio, and several previous comparative studies between microarray platforms and analysis procedures had indicated the very high sensitivity, reproducibility, and specificity using their recommended methods [ 28 ].”
MethodSelf-citationComparison of prognostic gene expression signatures for breast cancer
Haibe‐Kains, B., Desmedt, C., Piette, F., Buyse, M. E., Cardoso, F., Veer, L. V., Piccart, M. J., Bontempi, G., & Sotiriou, C. P. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-394 · Cited by 142
“Although the technology used has been shown to be ready for clinical practice [16], and can be used as one parameter in combination with current clinical parameters, these signatures need to be prospectively validated to prove their superiority and benefit above and beyond the use of standard clinico-pathological prog…”
BackgroundMethodCriteria for the use of omics-based predictors in clinical trials: explanation and elaboration
McShane, L. M., Cavenagh, M. M., Lively, T. G., Eberhard, D. A., Bigbee, W. L., Williams, P. M., Mesirov, J. P., Polley, M.-Y. C., Kim, K. Y., Tricoli, J. V., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-220 · Cited by 140
Rapid methods for diagnosis of bloodstream infections
Klouche, M., & Schröder, U. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.157 · Cited by 142
“Thus, quality control measures, as established for the use of microarrays in clinical and regulatory settings, are of central importance (107).”
BackgroundKim, M., Rai, N., Zorraquino, V., & Tagkopoulos, I. (2016) · Nature Communications · doi:10.1038/ncomms13090 · Cited by 138
Alexander-Dann, B., Pruteanu, L.-L., Oerton, E., Sharma, N., Berindan‐Neagoe, I., Módos, D., & Bender, A. (2018) · Molecular Omics · doi:10.1039/c8mo00042e · Cited by 149
Shi, L. M., Perkins, R., Fang, H., & Tong, W. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.11.003 · Cited by 139
Self-citationOzerov, I. V., Lezhnina, K. V., Izumchenko, E., Artemov, A. V., Medintsev, S., Vanhaelen, Q., Aliper, A., Vijg, J., Osipov, A. N., Labat, I., et al. (2016) · Nature Communications · doi:10.1038/ncomms13427 · Cited by 138
Role of Nuclear Factor κB in Ovarian Hormone-Mediated Stress Hypersensitivity in Female Mice
LaPlant, Q., Chakravarty, S., Vialou, V., Mukherjee, S., Koo, J. W., Kalahasti, G., Bradbury, K. R., Taylor, S. V., Maze, I., Kumar, A., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.024 · Cited by 136
“Finally, the data analysis criteria used for our study are recommended by the MicroArray Quality Control (MAQC) project, because these criteria have been validated to have the highest intersite reproducibility and interplatform and intraplatform reproducibility (36,37).”
MethodKlein, M. I., DeBaz, L., Agidi, S., Lee, H., Xie, G., Lin, A. H.-M., Hamaker, B. R., Lemos, J. A., & Koo, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013478 · Cited by 136
“The use of reference RNA as a normalization tool in microarray experiments reduces bias due to dye incorporation, eliminate the need for dye swap, and can be used for multiple comparisons as detailed elsewhere [25].”
MethodWen, Z., Wang, Z. K., Wang, S., Ravula, R., Yang, L., Xu, J., Wang, C., Zuo, Z., Chow, M. S. S., Shi, L. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018278 · Cited by 142
“In this study, genes differentially expressed between two sample groups were selected following the recommendations of the MAQC project [12,51].”
BackgroundMethodInfluentialSelf-citationVariance of Gene Expression Identifies Altered Network Constraints in Neurological Disease
Mar, J. C., Matigian, N. A., Mackay-Sim, A., Mellick, G. D., Sue, C. M., Silburn, P. A., McGrath, J. J., Quackenbush, J., & Wells, C. A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002207 · Cited by 132
Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop
Buesen, R., Chorley, B. N., Lima, B. S., Daston, G. P., Deferme, L., Ebbels, T. M. D., Gant, T. W., Goetz, A. K., Greally, J. M., Gribaldo, L., et al. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.09.002 · Cited by 147
Self-citationReplogle, K., Arnold, A. P., Ball, G. F., Band, M., Bensch, S., Brenowitz, E. A., Dong, S., Drnevich, J., Ferris, M., George, J. M., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-131 · Cited by 134
“These problems include not only differences in array design and fabrication but also differences in sampling handling [30-32] and differences in the approaches to analyse data from cDNA and short-oligo Affymetrix arrays.”
BackgroundChen-Plotkin, A. S., Geser, F., Plotkin, J. B., Clark, C. M., Kwong, L. K., Yuan, W., Grossman, M., Van Deerlin, V. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn023 · Cited by 135
“This has been observed in other studies as well (30,32), and likely reflects the greater amount of noise around microarray measurements, with their subsequent need for normalization.”
ResultIdentification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
Ross‐Macdonald, P., de Silva, H., Guo, Q., Xiao, H., Hung, C.-Y., Penhallow, B. A., Markwalder, J. A., He, L., Attar, R. M., Lin, T.-A., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0826 · Cited by 142
Sauer, U. G., Deferme, L., Gribaldo, L., Hackermüller, J., Tralau, T., van Ravenzwaay, B., Yauk, C., Poole, A., Tong, W., & Gant, T. W. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.09.020 · Cited by 132
Self-citationGrading of soft tissue sarcomas: from histological to molecular assessment
Neuville, A., Chibon, F., & Coindre, J. (2013) · Pathology · doi:10.1097/pat.0000000000000048 · Cited by 134
“It also demonstrates that microarray technologies are sufficiently reliable to be used for clinical and regulatory purposes.(35,36) Nevertheless, the excellent work by the MAQC consortium was performed using high-quality RNA extracted from fresh or frozen samples in optimal conditions.”
MethodYu, D., Huber, W., & Vitek, O. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt143 · Cited by 136
Liu, Z., Huang, R., Roberts, R., & Tong, W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.001 · Cited by 123
“However, a general rule can be followed, as suggested by the FDA-led MicroArray Quality Control (MAQC) consortium, to determine a reproducible DEG profile: ranking the genes by fold-change by comparing the treated with the control condition, followed by removing these genes with poor statistics (measured by a nonstrin…”
Self-citationQuality Assessment for Short Oligonucleotide Microarray Data
Brettschneider, J. A., Collin, F., Bolstad, B. M., & Speed, T. P. (2008) · Technometrics · doi:10.1198/004017008000000334 · Cited by 151
Metadata
- Authors
- MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., Kawasaki, E. S., Lee, K. Y., Luo, Y., Sun, Y. A., Willey, J. C., Setterquist, R. A., Fischer, G. M., Tong, W., Dragan, Y. P., Dix, D. J., Frueh, F. W., Goodsaid, F. M., Herman, D., Jensen, R. V., Johnson, C. D., Lobenhofer, E. K., Puri, R. K., Scherf, U., Thierry-Mieg, J., Wang, C., Wilson, M., Wolber, P. K., Zhang, L., Amur, S., Bao, W., Barbacioru, C. C., Lucas, A. B., Bertholet, V., Boysen, C., Bromley, B., Brown, D., Brunner, A., Canales, R., Cao, X. M., Cebula, T. A., Chen, J. J., Cheng, J., Chu, T.-M., Chudin, E., Corson, J., Corton, J. C., Croner, L. J., Davies, C., Davison, T. S., Delenstarr, G., Deng, X., Dorris, D., Eklund, A. C., Fan, X.-H., Fang, H., Fulmer-Smentek, S., Fuscoe, J. C., Gallagher, K., Ge, W., Guo, L., Guo, X., Hager, J., Haje, P. K., Han, J., Han, T., Harbottle, H. C., Harris, S. C., Hatchwell, E., Hauser, C. A., Hester, S., Hong, H., Hurban, P., Jackson, S. A., Ji, H., Knight, C. R., Kuo, W. P., LeClerc, J. E., Levy, S., Li, Q.-Z., Liu, C., Liu, Y., Lombardi, M. J., Ma, Y., Magnuson, S. R., Maqsodi, B., McDaniel, T., Mei, N., Myklebost, O., Ning, B., Novoradovskaya, N., Orr, M. S., Osborn, T. W., Papallo, A., Patterson, T. A., Perkins, R. G., Peters, E. H., Peterson, R., Philips, K. L., Pine, P. S., Pusztai, L., Qian, F., Ren, H., Rosen, M., Rosenzweig, B. A., Samaha, R. R., Schena, M., Schroth, G. P., Shchegrova, S., Smith, D. D., Staedtler, F., Su, Z., Sun, H., Szallasi, Z., Tezak, Z., Thierry-Mieg, D., Thompson, K. L., Tikhonova, I., Turpaz, Y., Vallanat, B., Van, C., Walker, S. J., Wang, S. J., Wang, Y., Wolfinger, R., Wong, A., Wu, J., Xiao, C., Xie, Q., Xu, J., Yang, W., Zhang, L., Zhong, S., Zong, Y., & Slikker, W.
- Affiliations
- Affymetrix (United States) (US)
- Illumina (United States) (US)
- Agilent Technologies (United States) (US)
- National Cancer Institute (US)
- National Center for Toxicological Research (US)
- Environmental Protection Agency (US)
- United States Food and Drug Administration (US)
- National Institutes of Health (US)
- University of Massachusetts Boston (US)
- Asuragen (United States) (US)
- Center for Biologics Evaluation and Research (US)
- Cedars-Sinai Medical Center (US)
- SAS Institute (United States) (US)
- Center for Food Safety and Applied Nutrition (US)
- Biogen (United States) (US)
- Yale University (US)
- Center for Veterinary Medicine (US)
- Cold Spring Harbor Laboratory (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Stanford Medicine (US)
- Harvard University (US)
- Vanderbilt University (US)
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- GenUs BioSystems (United States) (US)
- Oslo University Hospital (NO)
- The University of Texas MD Anderson Cancer Center (US)
- Luminex (United States) (US)
- Wake Forest University Health Sciences (US)
- University of Illinois Urbana-Champaign (US)
- ORCID
- Jones, Wendell D
- Collins, Patrick J
- Luo, Yuling
- Sun, Yongming Andrew
- Willey, James C
- Tong, Weida
- Frueh, Felix W
- Goodsaid, Federico M
- Johnson, Charles D
- Puri, Raj K
- Scherf, Uwe
- Wang, Charles
- Bao, Wenjun
- Brown, Donna
- Chen, James J
- Cheng, Jing
- Corton, J Christopher
- Croner, Lisa J
- Deng, Xutao
- Eklund, Aron C
- Fang, Hong
- Guo, Lei
- Guo, Xu
- Han, Jing
- Han, Tao
- Harbottle, Heather C
- Harris, Stephen C
- Hatchwell, Eli
- Hester, Susan
- Hong, Huixiao
- Jackson, Scott A
- Ji, Hanlee
- Levy, Shawn
- Li, Quan-Zhen
- Liu, Chunmei
- Liu, Ying
- Ma, Yunqing
- Mei, Nan
- Myklebost, Ola
- Ning, Baitang
- Patterson, Tucker A
- Pusztai, Lajos
- Qian, Feng
- Schroth, Gary P
- Su, Zhenqiang
- Sun, Hongmei
- Tikhonova, Irina
- Turpaz, Yaron
- Walker, Stephen J
- Wang, Sue Jane
- Wang, Yonghong
- Wong, Alex
- Wu, Jie
- Xiao, Chunlin
- Xie, Qian
- Xu, Jun
- Yang, Wen
- Zhang, Liang
- Zhong, Sheng
- Slikker, William
- Venue
- Nature Biotechnology
- Published
- 2006-09-01
- Volume
- 24
- Issue
- 9
- Pages
- 1151-1161
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3272078
- OpenAlex
- W2010637767
- Cited by
- 2,126
- References
- 43
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 23 · 2023: 39 · 2022: 37 · 2021: 60 · 2020: 43 · 2019: 59 · 2018: 68 · 2017: 87 · 2016: 87 · 2015: 98 · 2014: 122 · 2013: 155 · 2012: 160
- FWCI
- 87.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Funders
- U.S. Environmental Protection Agency
- National Institutes of Health (Z99 LM999999, Z99 HL999999, Z99 MH999999, Z99CL999999)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Molecular Biology Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- probe mapping, differentially expressed genes, microarray data analysis
- MeSH terms
- Equipment Design, Quality Assurance, Health Care, Quality Control, Sensitivity and Specificity, United States, Reproducibility of Results, Equipment Failure Analysis, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.